Ownership history in SHELL ASSET MANAGEMENT CO · 5 quarters on record
This page tracks every 13F SEC filing in which SHELL ASSET MANAGEMENT CO reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | REDUCED | 4,836 | -3,636 | -42.9% | 0.00% | $49K | $10.15 |
| 2025 Q1 | REDUCED | 8,472 | -352 | -4.0% | 0.00% | $47K | $5.58 |
| 2024 Q4 | UNCHANGED | 8,824 | — | 0% | 0.00% | $71K | $8.07 |
| 2024 Q3 | REDUCED | 8,824 | -141 | -1.6% | 0.00% | $90K | $10.25 |
As of 2025 Q4 — sorted by position size